Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
KRON Kronos Bio Inc
- Stocks
- Healthcare
- NASDAQ: KRON
Price (delayed)
$0.6812
Market cap
$41.53M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.07
Enterprise value
-$27.98M
Kronos Bio is a clinical-stage biopharmaceutical company dedicated to discovering and developing therapies that seek to transform the lives of those affected by cancer. The company focuses on targeting dysregulated
Highlights
Kronos Bio's quick ratio has soared by 72% from the previous quarter and by 60% YoY
Kronos Bio's EPS has increased by 46% YoY and by 25% QoQ
Kronos Bio's gross profit has increased by 21% YoY but it has decreased by 7% from the previous quarter
The company's revenue rose by 21% YoY but it fell by 7% QoQ
The equity has declined by 42% year-on-year and by 9% since the previous quarter
Key stats
What are the main financial stats of KRON
Market
Valuations
Earnings
Shares outstanding
60.97M
Market cap
$41.53M
Enterprise value
-$27.98M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.52
Price to sales (P/S)
4.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-3.04
Revenue
$9.19M
Gross profit
$9.19M
Operating income
-$70.34M
Net income
-$64.49M
EBIT
-$64.49M
EBITDA
-$63.82M
Free cash flow
-$54.38M
Per share
Balance sheet
Liquidity
EPS
-$1.07
EPS diluted
-$1.07
Free cash flow per share
-$0.89
Book value per share
$1.31
Revenue per share
$0.15
TBVPS
$1.78
Total assets
$108.14M
Total liabilities
$28.33M
Debt
$24.09M
Equity
$79.81M
Working capital
$93.99M
Debt to equity
0.3
Current ratio
12.93
Quick ratio
12.92
Net debt/EBITDA
1.09
Margins
Efficiency
Dividend
EBITDA margin
-694.3%
Gross margin
100%
Net margin
-701.5%
Operating margin
-765.2%
Return on assets
-47.2%
Return on equity
-64.2%
Return on invested capital
-97.7%
Return on capital employed
-64.3%
Return on sales
-701.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
KRON stock price
How has the Kronos Bio stock price performed over time
Intraday
-3.38%
1 week
-5.6%
1 month
-22.59%
1 year
-30.62%
YTD
-28.29%
QTD
-17.43%
Financial performance
How have Kronos Bio's revenue and profit performed over time
Revenue
$9.19M
Gross profit
$9.19M
Operating income
-$70.34M
Net income
-$64.49M
Gross margin
100%
Net margin
-701.5%
The operating margin has soared by 54% year-on-year and by 19% since the previous quarter
The net margin has soared by 54% YoY and by 20% QoQ
KRON's net income is up by 45% year-on-year and by 25% since the previous quarter
The operating income has grown by 44% YoY and by 24% from the previous quarter
Price vs fundamentals
How does KRON's price correlate with its fundamentals
Growth
What is Kronos Bio's growth rate over time
Valuation
What is Kronos Bio stock price valuation
P/E
N/A
P/B
0.52
P/S
4.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-3.04
Kronos Bio's EPS has increased by 46% YoY and by 25% QoQ
KRON's P/B is 60% below its 5-year quarterly average of 1.3 and 13% below its last 4 quarters average of 0.6
The equity has declined by 42% year-on-year and by 9% since the previous quarter
KRON's P/S is 32% below its last 4 quarters average of 6.6
The company's revenue rose by 21% YoY but it fell by 7% QoQ
Efficiency
How efficient is Kronos Bio business performance
Kronos Bio's return on sales has surged by 54% YoY and by 20% QoQ
The company's return on invested capital fell by 46% YoY and by 7% QoQ
Kronos Bio's ROA has increased by 15% from the previous quarter and by 9% YoY
The ROE rose by 14% QoQ and by 7% YoY
Dividends
What is KRON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for KRON.
Financial health
How did Kronos Bio financials performed over time
Kronos Bio's quick ratio has soared by 72% from the previous quarter and by 60% YoY
Kronos Bio's current ratio has surged by 71% QoQ and by 55% YoY
The debt is 70% lower than the equity
Kronos Bio's debt to equity has soared by 50% YoY and by 7% from the previous quarter
The equity has declined by 42% year-on-year and by 9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.